Caliber Imaging & Diagnostics Names Daniel Koon to Director of Global Sales Support

Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Daniel Koon to Director of Global Sales Support, effective immediately. Mr. Koon most recently served as Caliber I.D.'s Research Sales Manager, and prior to that held other positions within the company.

Mr. Koon has experience in international sales and support of Caliber's VivaScope® devices for research applications in clinical and preclinical dermatology. He has spent extended periods in Europe to help develop and implement strategies to assist the Company's European distribution partner MAVIG GmbH. He first joined Caliber more than 12 years ago, starting out as an engineering technician involved in the design and manufacturing aspects of the business, with subsequent promotions to Sales Application Engineer, Executive Account Manager and then Research Sales Manager.

Mr. Koon holds a bachelor's degree in mathematics and physics from the State University of New York College at Potsdam.

Mr. Koon said, "As I have been actively involved in global sales, sales support and engineering for the VivaScope system, I believe I have a unique understanding of it, and the procedures that need to be adhered to as the Company seeks to grow its medical and therapeutic research business. In my new role at Caliber, I look forward to helping to increase our support capability for our distribution partners around the globe."

L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "Having begun his career at Caliber as an engineer, Dan is extremely well-versed in VivaScope's technology, and he has the added advantage of having been an instrumental part of establishing business with our European distributor. In his new role, he will continue to build our customer support infrastructure. These activities are critical in helping us to generate additional revenue as we concurrently focus on the clinical side of the business. We expect him to excel in these efforts, mirroring his earlier success in facilitating our distribution in Europe."

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' proprietary, cutting-edge VivaScope(R) system is a disruptive, noninvasive point-of-care platform imaging technology with numerous applications in dermatology, surgery and research. FDA 510(k) cleared, VivaScope has regulatory approval in most major markets. With 78 issued or pending patents worldwide, VivaScope significantly improves outcomes and reduces costs, allowing physicians to quickly detect cancerous lesions that appear benign. VivaScope dramatically reduces the need for expensive, painful and time-consuming biopsies, which show no malignancy approximately 70% of the time. VivaScope also has significant applications in testing and analysis in the cosmetics industry. For more information about Caliber I.D. and its products, please visit www.caliberid.com.

VivaScope(R) is a registered trademark of Caliber Imaging & Diagnostics.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

CONTACT: Company Contact:
         Richard Pulsifer
         Chief Financial Officer
         [phone]
         
         Public Relations Contacts:
         Dian Griesel Int'l.
         Susan Forman or Laura Radocaj
         [phone]
         [e-mail]
         [e-mail]